National Trends in Maternal Use of Opioid Drugs among Pregnancy-Related Hospitalizations in the United States, 1998 to 2009

Abstract

Objective The aim of this study is to describe national trends for opioid use among pregnancy-related hospitalizations from 1998 to 2009.

Study Design Using the Nationwide Inpatient Sample, we identified hospital discharge records associated with the diagnoses codes for the use of opioids for all eligible pregnancy-related inpatient admissions between 1998 and 2009. Joinpoint regression modeling was used to describe changes in trend of pregnancy-related opioid use. The main outcome measure was the annual percent change for opioids use among pregnancy-related hospitalizations.

Results From 1998 to 2009, opioid use was documented in 138,224 of 55,781,966 pregnancy-related inpatient hospitalizations (25 cases per 10,000 discharges). A statistically significant downward trend occurred from 1998 to 2001, whereas from 2002 to 2009 there was a statistically significant upward trend. The increasing trend in opioid use from 2002 to 2009 is notably higher for whites compared with blacks and Hispanics.

Conclusions Our findings highlight the continuous need to monitor opioids use and to revise prescription guidelines, practices, and regulatory mechanisms to curtail the progression of the increasing opioids use during pregnancy. It is critical that health care providers weight the benefits of these medications along with their potential risks when discussing analgesic treatment options with pregnant women.

Keywords

pregnancy - opioids - trends - United States

• References

• 1 Substance Abuse and Maternal Health Services Adminstartion. Results from the 2011 national survery on drug use and health: summary of national findings. NSDUH Series H-44. Rockville, MD: SAHMSA; 2012
• 2 Cicero TJ, Inciardi JA, Muñoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain 2005; 6 (10) 662-672
• 3 Vallerand AH. The use of long-acting opioids in chronic pain management. Nurs Clin North Am 2003; 38 (3) 435-445
• 4 Manchikanti L, Abdi S, Atluri S , et al; American Society of Interventional Pain Physicians. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2—guidance. Pain Physician 2012; 15 (3, Suppl): S67-S116
• 5 Manchikanti L, Abdi S, Atluri S , et al; American Society of Interventional Pain Physicians. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I—evidence assessment. Pain Physician 2012; 15 (3, Suppl): S1-S65
• 6 Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain 2002; 18 (4, Suppl): S3-S13
• 7 Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician 2008; 11 (2, Suppl): S133-S153
• 8 Kenan K, Mack K, Paulozzi L. Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000-2010. Open Med 2012; 6 (2) e41-e47
• 9 Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006; 15 (9) 618-627
• 10 Manchikanti L, Helm II S, Fellows B , et al. Opioid epidemic in the United States. Pain Physician 2012; 15 (3, Suppl): ES9-ES38
• 11 Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006; 81 (2) 103-107
• 12 Back SE, Payne RL, Simpson AN, Brady KT. Gender and prescription opioids: findings from the National Survey on Drug Use and Health. Addict Behav 2010; 35 (11) 1001-1007
• 13 Bandstra ES, Morrow CE, Mansoor E, Accornero VH. Prenatal drug exposure: infant and toddler outcomes. J Addict Dis 2010; 29 (2) 245-258
• 14 Walhovd KB, Moe V, Slinning K , et al. Volumetric cerebral characteristics of children exposed to opiates and other substances in utero. Neuroimage 2007; 36 (4) 1331-1344
• 15 Fischer G. Treatment of opioid dependence in pregnant women. Addiction 2000; 95 (8) 1141-1144
• 16 Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012; 307 (18) 1934-1940
• 17 Pan IJ, Yi HY. Prevalence of hospitalized live births affected by alcohol and drugs and parturient women diagnosed with substance abuse at liveborn delivery: United States, 1999-2008. Matern Child Health J 2013; 17 (4) 667-676
• 18 Agency for Healthcare Research and Quality. Health care Cost and Utilization Project (HCUP). Introduction to the NIS:2009, HCUP NIS related reports. Rockville, MD: Agency for Healthcare Research and Quality; 2011
• 19 Merrill CTTH, Owens PLA. Reasons for being admitted to the hospital through the emergency department for children and adolescents, 2004. HCUP Statistical Brief #33. Rockville, MD: Agency for Healthcare Research and Quality; 2007
• 20 Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality. HCUP Quality Control Procedures. Rockville, MD; 2008
• 21 Kassed CA, Levit KR, Hambrick MM. Hospitalizations related to drug abuse, 2005. Statistical Brief #39 Rockville, MD Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality; 2008
• 22 Kim H-J, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19 (3) 335-351
• 23 Houchens R, Elixhauser A. Using the HCUP Nationwide Inpatient Sample to Estimate Trends. (Updated for 1988–2004). HCUP Methods Series Report #2006–05 Online: U.S. Agency for Healthcare Research and Quality; 2006
• 24 SAS Institute Inc. SAS/STAT® 9.3 User's Guide. Cary, NC: SAS Institute Inc.; 2011
• 25 Methodology S, Branch A. Joinpoint Regression Program, Version 4.0.1-January 9, 2013. Surveillance Research Program, National Cancer Institute; 2013
• 26 Epstein RA, Bobo WV, Martin PR , et al. Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol 2013; 23 (8) 498-503
• 27 Chen I, Kurz J, Pasanen M , et al. Racial differences in opioid use for chronic nonmalignant pain. J Gen Intern Med 2005; 20 (7) 593-598
• 28 Becker WC, Starrels JL, Heo M, Li X, Weiner MG, Turner BJ. Racial differences in primary care opioid risk reduction strategies. Ann Fam Med 2011; 9 (3) 219-225
• 29 Younger JW, Chu LF, D'Arcy NT, Trott KE, Jastrzab LE, Mackey SC. Prescription opioid analgesics rapidly change the human brain. Pain 2011; 152 (8) 1803-1810
• 30 Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med 2011; 12 (4) 657-667
• 31 Broussard CS, Rasmussen SA, Reefhuis J , et al; National Birth Defects Prevention Study. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011; 204 (4) e1-e11
• 32 Joranson DE. Federal and state regulation of opioids. J Pain Symptom Manage 1990; 5 (1, Suppl): S12-S23
• 33 Joranson DE, Gilson AM, Dahl JL, Haddox JD. Pain management, controlled substances, and state medical board policy: a decade of change. J Pain Symptom Manage 2002; 23 (2) 138-147
• 34 Federation of State Medical Boards of the United States. Model guidelines for the use of controlled substances for the treatment of pain. S D J Med 1999; 52 (1) 25-27
• 35 Center For Substance Abuse Work Group; Federation of State Medical Boards. Model policy guidelines for opioid addiction treatment in the medical office. Pain Physician 2003; 6 (2) 217-221
• 36 Federation of State Medical Boards of the United States, Inc. Model policy for the use of controlled substances for the treatment of pain. J Pain Palliat Care Pharmacother 2005; 19 (2) 73-78
• 37 Sandlin D. The new Joint Commission Accreditation of Healthcare Organizations' requirements for pain assessment and treatment: a pain in the assessment?. J Perianesth Nurs 2000; 15 (3) 182-184
• 38 Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 2010; 13 (5) 401-435
• 39 Zhao J, Stockwell T, Macdonald S. Non-response bias in alcohol and drug population surveys. Drug Alcohol Rev 2009; 28 (6) 648-657